Be careful as its not approve yet as stated in the accouncement.
The joint venture
has been formed to market and sell the
Canntab proprietary products in
Australia with a first right to distribute throughout Asia
.
VitaCann and CannTab
will work towards having Canntab’s tablets formally approved
for sale in Australia and to export to Asia
.
Pursuant to recent and evolving legislation in Australia, the Canntab
product should qualify for approval as it should meet all the standard medical requirements that would be expected by
the medical industry and deals with the above-mentioned issues and without the problems that nearly all other Cannabis products to date have faced
.
We believe that the patents filed and pending protects
key features of our IP,and position.
QBL Price at posting:
5.2¢ Sentiment: Buy Disclosure: Not Held
